Authors: HATCHER JP LOUDON JM HAGAN JJ CLARK MSG

Citation: Jp. Hatcher et al., SABCOMELINE (8B-202026), A FUNCTIONALLY SELECTIVE M-1 RECEPTOR PARTIAL AGONIST, REVERSES DELAY-INDUCED DEFICITS IN THE T-MAZE, Psychopharmacology, 138(3-4), 1998, pp. 275-282

Authors: LOUDON JM BROMIDGE SM BROWN F CLARK MSG HATCHER JP HAWKINS J RILEY GJ NOY G ORLEK BS

Citation: Jm. Loudon et al., SE-202026 - A NOVEL MUSCARINIC PARTIAL AGONIST WITH FUNCTIONAL SELECTIVITY FOR M-1 RECEPTORS, The Journal of pharmacology and experimental therapeutics, 283(3), 1997, pp. 1059-1068

Authors: BROMIDGE SM BROWN F CASSIDY F CLARK MSG DABBS S HADLEY MS HAWKINS J LOUDON JM NAYLOR CB ORLEK BS RILEY GJ

Citation: Sm. Bromidge et al., DESIGN OF OXYIMINO)-1-AZABICYCLO[2.2.2]OCTANE-3-ACETONITRILE (SB-202026), A FUNCTIONALLY SELECTIVE AZABICYCLIC MUSCARINIC M1 AGONIST INCORPORATING THE N-METHOXY IMIDOYL NITRILE GROUP AS A NOVEL ESTER BIOISOSTERE()), Journal of medicinal chemistry, 40(26), 1997, pp. 4265-4280

Authors: LOUDON JM

Citation: Jm. Loudon, MUSCARINIC PARTIAL AGONISTS IN THE TREATMENT OF ALZHEIMERS-DISEASE, British Journal of Pharmacology, 120, 1997, pp. 384-384

Authors: BROMIDGE SM BROWN F CASSIDY F CLARK MSG COLLINGS EJ DABBS S FAULKNER RE LOUDON JM ORLEK BS RILEY GJ

Citation: Sm. Bromidge et al., 1,2,5,6-TETRAHYDROPYRIDINE OXIME ETHERS INCORPORATING ELECTRON-WITHDRAWING GROUPS ARE POTENT AND SELECTIVE MUSCARINIC AGONISTS, Bioorganic & medicinal chemistry letters, 4(4), 1994, pp. 557-562